Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
British Journal of Clinical Pharmacology|May 3, 2020
Population pharmacokinetics of regorafenib in solid tumours: Exposure in clinical practice considering enterohepatic circulation and food intakeAnne Keunecke, Sven Hoefman, Henk-Jan Drenth, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 16, 2025
From In Vitro Efficacy to Long-Term HbA1c Response for GLP-1R/GlucagonR Agonism Using the 4GI-HbA1c Systems ModelRolien Bosch, Marcella Petrone, Rosalin Arends, et al.
Plos One|April 28, 2012
Survival or revival: long-term preservation induces a reversible viable but non-culturable state in methane-oxidizing bacteriaSven Hoefman, Koenraad Van Hoorde, Nico Boon, et al.
BMC Microbiology|April 9, 2014
Niche differentiation in nitrogen metabolism among methanotrophs within an operational taxonomic unitSven Hoefman, David van der Ha, Nico Boon, et al.
Antonie Van Leeuwenhoek|November 26, 2013
Customized media based on miniaturized screening improve growth rate and cell yield of methane-oxidizing bacteria of the genus MethylomonasSven Hoefman, David van der Ha, Nico Boon, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 15, 2020
Population pharmacokinetics and pharmacodynamics of a novel vascular adhesion protein-1 inhibitor using a multiple-target mediated drug disposition modelNelleke Snelder, Sven Hoefman, Alberto Garcia-Hernandez, et al.
Applied Microbiology and Biotechnology|December 17, 2013
Atmospheric methane removal by methane-oxidizing bacteria immobilized on porous building materialsGiovanni Ganendra, Willem De Muynck, Adrian Ho, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 10, 2021
A novel integrated QSP model of in vivo human glucose regulation to support the development of a glucagon/GLP-1 dual agonistRolien Bosch, Marcella Petrone, Rosalin Arends, et al.
British Journal of Pharmacology|February 25, 2024
Characterisation of cotadutide's dual GLP-1/glucagon receptor agonistic effects on glycaemic control using an in vivo human glucose regulation quantitative systems pharmacology modelRolien Bosch, Marcella Petrone, Rosalin Arends, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 15, 2020
Mechanism-based modeling of the effect of a novel inhibitor of vascular adhesion protein-1 on albuminuria and renal function markers in patients with diabetic kidney diseaseSven Hoefman, Nelleke Snelder, Martijn van Noort, et al.
Pageof 3